Enovis (ENOV) Change in Receivables (2010 - 2026)
Enovis' (ENOV) quarterly Change in Receivables came in at -$1.1 million in Q3 2026, down 122.36% year-over-year from $4.8 million in Q3 2025, and down 124.94% quarter-over-quarter from $4.3 million in Q2 2026.
Analysis
Enovis (ENOV) Change in Receivables (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Change in Receivables for 17 consecutive years, with -$1.1 million the latest figure, recorded in Q3 2026.
- On a quarterly basis, Change in Receivables fell 122.36% year-over-year to -$1.1 million in Q3 2026; TTM through Jul 2026 was -$6.8 million, a 112.83% decrease from a year earlier, with the FY2025 full-year figure at $10.8 million, down 81.15% from the prior year.
- Change in Receivables was -$1.1 million for Q3 2026 at Enovis, down from $4.3 million in the prior quarter.
- Over five years, Change in Receivables peaked at $27.9 million in Q4 2024 and troughed at -$20.8 million in Q4 2025.
- A 5-year average of $7.4 million and a median of $10.5 million in 2022 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables surged 422.36% in 2023 and slumped 575.05% in 2025, its largest moves.
- Over 5 years, Change in Receivables stood at $1.9 million in 2022, then surged by 422.36% to $9.8 million in 2023, then surged by 184.65% to $27.9 million in 2024, then tumbled by 61.47% to $10.7 million in 2025, then tumbled by 110.1% to -$1.1 million in 2026.
- The last three Change in Receivables figures came in at -$1.1 million (Q3 2026), $4.3 million (Q2 2026), and $10.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 74.90 Mn |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn | -224.00 Mn |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn | 177.00 Mn |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn | 46.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 10.20 Mn |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn | 172.10 Mn |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Enovis | 1.07 Bn | 1.06 Bn | 359.25 Mn | -1.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | -1.08 Mn |
| Apr 3, 2026 | 4.35 Mn |
| Dec 31, 2025 | 10.74 Mn |
| Oct 3, 2025 | -20.81 Mn |
| Jul 4, 2025 | 4.85 Mn |
| Apr 4, 2025 | 15.98 Mn |
| Dec 31, 2024 | 27.86 Mn |
| Sep 27, 2024 | 4.38 Mn |
| Jun 28, 2024 | 12.80 Mn |
| Mar 29, 2024 | 12.01 Mn |
| Dec 31, 2023 | 9.79 Mn |
| Sep 29, 2023 | -19.39 Mn |
| Jun 30, 2023 | 13.62 Mn |
| Mar 31, 2023 | 12.29 Mn |
| Dec 31, 2022 | 1.87 Mn |
| Sep 30, 2022 | 10.19 Mn |
| Jul 1, 2022 | 12.43 Mn |
| Apr 1, 2022 | 20.69 Mn |
| Dec 31, 2021 | 40.58 Mn |
| Oct 1, 2021 | -13.05 Mn |